Abhay Pandey | Herbal Medicine and Nutraceuticals | Best Researcher Award

Published on 13/03/202513/03/2025 by Top Pharmaceutical

Abhay Pandey | Herbal Medicine and Nutraceuticals | Best Researcher Award

Prof. Dr. Abhay Pandey, University of Allahabad, Prayagraj, India

Prof. Dr. Abhay Pandey is a distinguished biochemist 🧬 and professor at the University of Allahabad 🏛️, specializing in oxidative stress, free radical biology, and natural product biochemistry 🌿. With a Ph.D. in Biochemistry (1993) 🎓, he has over 29 years of academic experience 📚, supervising 12 Ph.D. scholars and 45 M.Sc. dissertations. He has held key administrative roles, including Head of Biochemistry and Assistant Dean. A fellow of NASI and SBC India, he has received prestigious awards 🏆 like the Dr. Sarvepalli Radhakrishnan Education Promotion Award. His impactful research continues to shape the scientific community 🌟.

Publication Profile

Google Scholar

Education

Prof. Dr. Abhay Pandey holds an impressive academic background in life sciences. 🎓 He earned his B.Sc. in Zoology, Botany, and Chemistry (1982) and an M.Sc. in Biochemistry (1984) from the University of Allahabad, both with first-division honors. 🏅 He qualified for the UGC JRF-NET in Life Sciences (1986) and pursued a Ph.D. (1993) on the “Study of interaction of metal ions with biologically important adenine nucleotides.” 🧬 Additionally, he completed DIM (1997) and PGDIM (1998) from IGNOU. 📚 A recipient of the National and State Merit Scholarships, he also availed JRF & SRF for his research contributions. 🏆

Experience

Prof. Dr. Abhay Pandey has undergone extensive professional training in advanced biotechnological fields. 🧬 He participated in workshops on DNA vaccines (2002) and Recombinant DNA Technology for Vaccine Development (2001) at IVRI, Bareilly. Additionally, he trained in ISO 9000 QA System implementation (1998). ✅ His administrative roles include serving as Head of the Biochemistry Department at the University of Allahabad (2017–2019) and SBSPGI, Dehradun (2002–2004). 🎓 He has held key positions such as Assistant Proctor, Assistant Dean (Students’ Welfare), Warden, and Chairman of multiple university committees. 🏛️ He also contributes as DBT Nominee for Biosafety at MNNIT, Prayagraj. 🔬

Awards

Prof. Dr. Abhay Pandey has received numerous prestigious honors for his contributions to science and education. 🏆 He serves as Associate Editor-in-Chief for VEGETOS (Springer) and as Associate Editor for BMC Complementary and Alternative Medicine (Springer). 📖 He was a Guest Associate Editor for Frontiers in Pharmacology (2020–21). His accolades include the Dr. Sarvepalli Radhakrishnan Education Promotion Award (2019) 🎖️ and the Distinguished Scientist Award (2016) by SPR. He has been recognized as a Distinguished Academician (2012) and received the Fellow Award (2011–12). ✨ In 2010, he was granted an International Travel Award by DST, India, to visit Spain. ✈️

Research Focus

Prof. Dr. Abhay Pandey is a distinguished researcher in phytochemistry 🌿, medicinal chemistry 🧪, and natural product pharmacology 💊. His research primarily focuses on the biological activities of flavonoids, polyphenols, and other plant-derived compounds, particularly their antioxidant 🛡️, antimicrobial 🦠, anticancer 🎗️, and anti-inflammatory 🔬 properties. He has extensively studied the therapeutic potential of medicinal plants 🌱, their role in gut microbiota modulation 🦠, and their application in metabolic disorders 🔄. His work also explores histone deacetylase inhibitors for cancer treatment and the AMPK pathway in diabetes. His contributions significantly advance phytomedicine and natural drug discovery 🏆

Publication Top Notes

Chemistry and biological activities of flavonoids: an overview

Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency

Bauhinia variegata leaf extracts exhibit considerable antibacterial, antioxidant, and anticancer activities

Antioxidant mediated protective effect of Parthenium hysterophorus against oxidative damage using in vitro models

Therapeutic potential of Aloe vera-A miracle gift of nature

Scientific validation of the medicinal efficacy of Tinospora cordifolia

Inhibitory activity of Indian spice plant Cinnamomum zeylanicum extracts against Alternaria solani and Curvularia lunata, the pathogenic dematiaceous moulds

Targeting histone deacetylases with natural and synthetic agents: an emerging anticancer strategy

Antifungal and antioxidative potential of oil and extracts derived from leaves of Indian spice plant Cinnamomum tamala

Anti-staphylococcal activity of a pan-tropical aggressive and obnoxious weed Parthenium histerophorus: an in vitro study.

Free radicals: health implications and their mitigation by herbals

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Published on 12/03/202512/03/2025 by Top Pharmaceutical

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Dr. nisreen kaddim, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nisreen Kaddim Radi is an Assistant Professor at the University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🧬. Her research focuses on antimicrobial resistance, food safety, and innovative antibacterial films for medical applications 🏥. She has presented at international conferences and published extensively in high-impact journals 📚. Passionate about advancing science, she integrates computational and experimental approaches to explore anticancer and antibacterial agents ⚗️. With a commitment to research and education, Dr. Nisreen inspires students and contributes to scientific innovation 🌍.

Publication Profile

Google Scholar

Professional Background

Dr. Nisreen Kaddim Radi 🎓 is an Assistant Professor at the College of Science for Women, University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🦠, with a focus on food safety and packaging 🍱. She is a member of the Arab Association for Science and Technology, Iraq branch, and serves on the Educational Guidance Committee at her college. Dr. Nisreen has published numerous research papers and actively participates in global conferences 🌍, including the 2022 International Conference on Sustainable Development Goals in Istanbul, ICAB 2022 at the University of Basrah, and ICAB2 2024, where she presented her studies on antimicrobial resistance, genetic variation, and immunological research

Memberships

Dr. Nisreen Kaddim Radi 🔬 is a dedicated researcher with significant contributions to molecular biology, genetics, and virology 🧬. Although she does not hold editorial positions or industry collaborations, her active engagement in scientific research strengthens her impact in the field. As a member of the Arab Association for Science and Technology 🌍, she remains connected to a network of experts, enhancing her academic and professional credibility. Through her research and participation in international conferences, Dr. Nisreen continues to contribute valuable insights to the scientific community, particularly in food safety and antimicrobial resistance 🦠.

Innovation in Methodology

Dr. Nisreen Kaddim Radi 🔬 combines computational simulations with experimental studies to develop innovative methods for enhancing the effectiveness of antibacterial and anticancer agents 🦠🎗️. Her dual-approach methodology integrates cutting-edge technology with practical applications, demonstrating a high level of scientific innovation 🚀. By bridging computational modeling with real-world experimentation, she contributes to advancing medical and pharmaceutical research, aligning perfectly with the award’s objectives 🏆. Her work not only improves therapeutic outcomes but also paves the way for more efficient and targeted treatments, reinforcing her role as a leading researcher in molecular biology and biotechnology 🧬.

Research Excellence

Dr. Nisreen Kaddim Radi 🔬 is pioneering the development of antibacterial films by integrating nanomaterials, polymers, and plant extracts 🌱🦠. Her innovative approach has profound implications for both medical and industrial applications 🏥🏭, positioning her at the forefront of antibacterial and anticancer material research 🎗️. Her groundbreaking study, Integrative Computational and Experimental Study of Propolis, Polyvinyl Alcohol, and Alhagi maurorum Complex as Anticancer and Antibacterial Agents 📜, showcases a multidisciplinary methodology, blending computational modeling with experimental validation 💻⚗️. This research enhances therapeutic potential, contributing to the advancement of novel biomedical materials and precision-targeted treatments 🚀.

Research Focus

Dr. Nisreen Kaddim Radi’s research primarily focuses on medical microbiology 🦠, immunology 🧬, and infectious diseases 🏥. Her work extensively explores viral infections such as Varicella Zoster Virus (VZV) 🏵️, Human Papillomavirus (HPV) 🎗️, and Hepatitis B Virus (HBV) 🦠, investigating genetic susceptibility and immune response. She also examines bacterial resistance 🧫, particularly in foodborne pathogens like E. coli, and studies immunological markers 🧪 in various infections. Her contributions in genetic polymorphisms 🔬, cytokine responses 🌡️, and molecular typing of pathogens highlight her expertise in understanding disease mechanisms and improving diagnostic approaches in infectious diseases and immunological disorders.

Publication Top Notes

Investigation of oxidative stress in patient with Varicella Zoster Virus (VZV) infection

Human genetic variation susceptibility associated with HBV: analysis of genetic markers susceptibility to hepatitis b among patients in babylon province

Genetic study of TORCH infections in women with bad obstetric history: multiplex polymerase chain reaction for detection of common pathogens and agents of congenital infections

Evaluation of CD4 and CD8 in Patients Infected with Genital Wart Caused by Human Papilloma Virus in Babylon Province/Iraq

Evaluation of serum IgE, TNF alpha at patients with genital warts, Iraq.

Immunological Study for Patient with Verruca Vulgaris and Verruca Plana Caused by HPV in Hilla/Iraq

The effect of manganese poisoning on the histological structure of testis in male Swiss mice

Bacteriological Study of Tonsillitis Patients and Estimation of Concentrations of Certain Immunological Parameters.

The distribution of antimicrobial resistance and the presence of virulence genes in Escherichia coli isolated from frozen chicken meat in Iraq

Henryk Mazurek | Precision Medicine | Best Researcher Award

Published on 12/03/202512/03/2025 by Top Pharmaceutical

Henryk Mazurek | Precision Medicine | Best Researcher Award

Prof. Henryk Mazurek, National Tuberculosis and Lung Diseases Institute, Department of Pneumonology and Cystic Fibrosis, Poland

Prof. Henryk Mazurek is a distinguished pulmonologist, allergologist, and pediatrician specializing in pediatric pulmonology and respiratory diseases. He serves as the Head of the Department of Pneumonology and Cystic Fibrosis at the National Tuberculosis and Lung Diseases Institute, Poland 🇵🇱. With over 60 original research articles and extensive contributions to medical literature 📚, he has significantly advanced the understanding of chronic respiratory diseases, asthma, and cystic fibrosis. A member of esteemed scientific societies 🌍, he actively collaborates internationally and leads impactful research projects. His work in AI-assisted diagnostics and pulmonary care is shaping the future of respiratory medicine. 🚀

Publication Profile

Scopus

Professional Background

Professor Henryk Mazurek is a distinguished pulmonary disease specialist, allergologist, pediatrician, and pediatric pulmonology expert 🩺. He completed postgraduate studies in respiratory pathophysiology in France 🇫🇷 and holds the title of Full Professor in medical and health sciences 🎓. As an academic, he teaches nursing and postgraduate medical training in pediatrics, allergology, and lung diseases. He has authored and co-authored over 60 original articles, 100+ textbook chapters, and numerous scientific publications 📚. A sought-after lecturer, he shares his expertise at medical conferences, educating physicians and healthcare professionals worldwide 🌍.

Memberships

Prof. Henryk Mazurek is an esteemed member of several prestigious scientific organizations, fostering international collaboration in respiratory medicine 🌍🫁. He holds a combined membership in the European Respiratory Society (ERS) / Polish Respiratory Society, along with memberships in the Polish Society of Allergology and the Polish Society of Pediatric Pulmonology, where he is an honorary member 🎖️. For many years, he contributed to the Scientific Council of the Institute of Tuberculosis and Lung Diseases in Warsaw 🏥. Additionally, he served on the Main Boards of the Polish Society of Allergology (2015-2021) and the Polish Society of Cystic Fibrosis (2014-2018) 📚.

Industry Projects

Prof. Henryk Mazurek has actively contributed to over 50 industry-sponsored clinical trials, showcasing his expertise in applied research 🔬. His consultancy work plays a crucial role in bridging academic research with real-world healthcare applications, particularly in advancing treatment strategies for cystic fibrosis 🫁. Through his collaborations with pharmaceutical and medical device companies 💊🩺, he has successfully translated research findings into clinical practice, improving patient outcomes. His dedication to innovation and evidence-based solutions continues to shape the future of respiratory medicine, reinforcing his impact on both academia and industry. 🌍

Research Focus

Prof. Henryk Mazurek’s research primarily focuses on respiratory diseases 🫁, particularly in cystic fibrosis 🧬, pediatric pulmonology 👶, and ventilator-associated pneumonia 🏥. His work explores innovative AI-facilitated home monitoring 🤖 for cystic fibrosis, childhood asthma treatments 🌬️, and the effects of medications like Gabapentin on post-operative pain 💊. He has also studied risk factors for pneumonia 🦠 and strategies for its prevention in ventilated patients. His expertise lies in pulmonary infections, inflammatory biomarkers, and personalized medicine 🧑‍⚕️. His contributions significantly impact respiratory healthcare, enhancing diagnostic and therapeutic approaches for both pediatric and adult patients.

Publication Top Notes

AI-facilitated home monitoring for cystic fibrosis exacerbations across pediatric and adult populations

Childhood asthma treatment based on indirect hyperresponsiveness test: Randomized controlled trial

The Effects of Gabapentin on Post-Operative Pain and Anxiety, Morphine Consumption and Patient Satisfaction in Paediatric Patients Following the Ravitch Procedure—A Randomised, Double-Blind, Placebo-Controlled, Phase 4 Trial

Risk Factors and Protective Factors against Ventilator-Associated Pneumonia—A Single-Center Mixed Prospective and Retrospective Cohort Study

Automatic continuous control of cuff pressure and subglottic secretion suction used together to prevent pneumonia in ventilated patients—a retrospective and prospective cohort study

Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6

Edwin Posadas | Precision Medicine | Best Researcher Award

Published on 12/03/202512/03/2025 by Top Pharmaceutical

Edwin Posadas | Precision Medicine | Best Researcher Award

Dr. Edwin Posadas, Cedars-Sinai Cancer, United States

Dr. Edwin M. Posadas is a distinguished oncologist and urologist specializing in prostate cancer research and treatment. He is a Professor at Cedars-Sinai Medical Center and UCLA, co-Director of the Cancer Therapeutics Program, and Medical Director of the Urologic Oncology Program. A Johns Hopkins graduate, he trained at the NIH and University of Michigan. Dr. Posadas has earned numerous accolades, including Castle Connolly Top Doctor and Sigma Xi Honors. An active researcher, mentor, and leader in oncology, he contributes to multiple scientific committees and journals, shaping the future of cancer care. 📚🔬✨

Publication Profile

orcid

Education

Dr. Edwin Posadas 🎓 began his academic journey at Johns Hopkins University, earning dual B.E.S. degrees in Biomedical and Chemical Engineering (1993) with summa cum laude honors. His studies focused on biological transport systems and physiological fluid mechanics. He then pursued his M.D. at Johns Hopkins School of Medicine (1998) 🩺, followed by an internship and residency at the University of Michigan Medical Center (2001) 🏥. Further specializing, he completed a fellowship in Medical Oncology and Hematology (2005) 🧬 at the National Cancer Institute & National Heart, Lung, and Blood Institute, solidifying his expertise in cancer research and treatment. 🔬💙

Professional Associations

Dr. Edwin Posadas 🩺 is an esteemed member of numerous professional associations and scholarly societies, reflecting his dedication to oncology, urology, and medical ethics. He joined the American Medical Association (1993) 🏥, Association of Philippine Physicians of America (1998) 🇵🇭, and American College of Physicians (1998) 🩻, later becoming a Fellow (2010) 🎖️. His contributions extend to the American Society of Clinical Oncology (2001) 🧬, American Association for Cancer Research (2001) 🔬, and European Society of Medical Oncology (2012) 🌍. He also actively participates in cancer research initiatives, including the Cancer Moonshot Program (2016) 🚀 and the Medical Oncology Association of Southern California (2022) 🌿.

Achievements

Dr. Edwin Posadas 🩺 has built a distinguished career in internal medicine and medical oncology, dedicated to advancing patient care and cancer research. In 2001, he became certified in Internal Medicine 🏥, laying the foundation for his expertise in diagnosing and managing complex diseases. His passion for oncology led him to further specialize, earning his Medical Oncology certification in 2019 🧬🎗️. With decades of experience, he remains committed to innovative cancer treatments, translational research, and personalized patient care, making significant contributions to the oncology community through clinical practice, research, and professional collaborations. 🔬💙

Research Focus

Dr. Edwin M. Posadas is a distinguished researcher specializing in prostate cancer 🔬, metastasis 🧬, and nanotechnology-based diagnostics 🏥. His work focuses on understanding the molecular determinants of metastasis in prostate cancer, particularly liver and visceral metastases. He has contributed to the development of nanotechnology solutions for early cancer detection 🩸 and circulating tumor cell profiling. His research also explores the role of FYN kinase in cancer growth and motility. With multiple grants from the National Cancer Institute and Congressionally Directed Medical Research Programs, his pioneering work is advancing precision oncology and metastasis prevention in prostate cancer patients. 🎗️

Publication Top Notes

Determinants of Liver Metastasis

A Nanotechnology Solution for Early Detection of Micrometastatic Prostate Cancer After Radical Prostatectomy

A blood test to identify prostate cancer patients at risk for visceral metastasis

Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling

FYN Is a Key Regulator of Metastasis in Prostate Cancer

Targeting FYN in Prostate Cancer: A Key Regulator of Growth and Motility

KYU SHIK MUN | Personalized Medicine | Best Researcher Award

Published on 11/03/202511/03/2025 by Top Pharmaceutical

KYU SHIK MUN | Personalized Medicine | Best Researcher Award

Assist. Prof. Dr. KYU SHIK MUN, Cedars-Sinai Medical Center, United States

Assist. Prof. Dr. Kyu Shik Mun is a distinguished researcher in cystic fibrosis (CF) and biomedical engineering 🧬. As a Principal Investigator and Co-Director, he has led groundbreaking projects on CF-related diabetes, organ-on-a-chip models, and personalized CF therapy 🏥. His work, funded by organizations like the Cystic Fibrosis Foundation and Vertex Pharmaceuticals, has yielded significant patents and high-impact publications 📑. With 733 citations, an h-index of 10, and an i10-index of 10, Dr. Mun continues to drive innovations in CF research, bridging biomedical science and translational medicine 🔬.

Publication Profile

Google Scholar

Professional Background

Assist. Prof. Dr. Kyu Shik Mun earned his Ph.D. in the Materials Science and Engineering Program at the University of Cincinnati 🎓. In 2016, he joined the Cystic Fibrosis Research Center at Cincinnati Children’s Hospital, where he pioneered a microfluidic-based organ-on-chip program from scratch 🏥🧬. His groundbreaking research focused on studying cystic fibrosis and related disorders. In 2021, he was promoted to Assistant Professor at Cedars-Sinai 🏆, where he continues to advance in vitro cell culture models using organ-on-chip technology and 3D bioprinting 🖨️🔬, contributing to innovative solutions in biomedical research and personalized medicine.

Awards

Assist. Prof. Dr. Kyu Shik Mun has received numerous prestigious honors and awards throughout his academic and professional journey 🎖️. He was awarded multiple Outstanding Grade Scholarships at Gangneung National University 🏅 (2000–2009) and recognized for excellence with department and presidential awards 🏆. His achievements include a scholarship from the Korean Broadcasting System 📺 and the Korea Research Foundation 🌏. During his Ph.D. at the University of Cincinnati, he earned a University Graduate Scholarship 🎓 (2010–2014). His research has been recognized by the American Gastroenterological Association and the Cystic Fibrosis Foundation 🧬, receiving multiple Best Abstract and Early Career Investigator awards (2017–2024) 🥇.

Experience

Assist. Prof. Dr. Kyu Shik Mun has been actively involved in non-clinical teaching, contributing to journal clubs and lab mentoring 📚🎤. He has delivered key presentations on organ-on-a-chip technology 🧬, including talks at Cincinnati Children’s Hospital (2020) and Cedars-Sinai (2021) 🏥. His mentorship spans postdoctoral fellows, research associates, and Ph.D. students, guiding projects in 3D bioprinting 🖨️ and patient-derived lung-on-a-chip models 🌬️. Since 2016, he has mentored 15 summer and rotation students—including high school, college, Ph.D., and MD candidates—on fabricating organ-on-a-chips and culturing cells, fostering the next generation of biomedical researchers 🔬.

Research Focus

Assist. Prof. Dr. Kyu Shik Mun’s research primarily focuses on nanotechnology 🧪, biosensors 🧫, and biomedical engineering 🏥. His work spans optical interferometric biosensors for label-free detection, organ-on-a-chip models for diseases like cystic fibrosis 🫁, and TiO₂ nanotube arrays for applications in solar cells ☀️ and photocatalysis. He also explores drug discovery 💊 by targeting molecular pathways in cystic fibrosis and related disorders. His interdisciplinary research integrates materials science 🏗️, biophysics ⚛️, and microfluidics 🔬 to develop innovative medical technologies, aiming to advance precision medicine 🎯 and renewable energy solutions 🌱.

Publication Top Notes

A Stable, Label-free Optical Interferometric Biosensor Based on TiO₂ Nanotube Arrays

Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders

Guided construction of single cell reference for human and mouse lung

Targeting the pregnane X receptor using microbial metabolite mimicry

Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations

Surface passivation of highly ordered TiO2 nanotube arrays and application to dye-sensitized solar cells using the concept of isoelectric point

Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR

Guanylate cyclase 2C agonism corrects CFTR mutants

Cystic Fibrosis Human Organs-on-a-Chip

Alberto Leyva | Biopharmaceutics | Best Researcher Award

Published on 10/03/202510/03/2025 by Top Pharmaceutical

Alberto Leyva | Biopharmaceutics | Best Researcher Award

Prof. Alberto Leyva, Center for Genetic Engineering and Biotechnology, Cuba

🔬 Prof. Alberto Leyva Gálvez (b. September 18, 1976) is a Cuban microbiologist and expert in biopharmaceutical systems. 🎓 He holds a Master’s in Science and has served at the Center for Genetic Engineering and Biotechnology since 2003. 🏭 As Head of Critical Systems, he specializes in analytical validation, antibody purification, and regulatory compliance. 📑 With 18 scientific publications, he has led key projects in water treatment, system validation, and quality assurance. 🏅 A dedicated educator, he conducts training in biotechnology, validation, and risk management. His expertise ensures excellence in biopharmaceutical production and regulatory standards. ✅

Publication Profile

Scopus

Education

Professor Alberto Leyva is a distinguished microbiologist with a strong academic and research background. He earned his Licenciado en Microbiología degree in 2003 from the Universidad de la Habana 🎓 and later obtained a Master en Ciencias. Currently, he serves as an Investigador Auxiliar 🧪 and holds the title of Tecnólogo de I Nivel in the field of biotechnology. Since September 2003, he has been contributing to groundbreaking research at the Centro de Ingeniería Genética y Biotecnología 🔬, where he continues to advance scientific knowledge. His dedication to microbiology and biotechnology makes him a key figure in his field.

Professional Experience

Professor Alberto Leyva has extensive experience in microbiology and biotechnology, specializing in immunochemical techniques and analytical method validation 🧪. He has worked on antibody purification through affinity columns and has authored 18 scientific articles in international journals 📚. His expertise includes design, qualification, and validation of critical systems such as water, pure steam, and compressed air 💧. He has conducted FAT and SAT testing and participated in regulatory inspections . Additionally, he has contributed to water recovery and reuse in production plants and managed critical and auxiliary systems ⚙️. He also teaches courses on validation and maintenance in biopharmaceutical industries.

Global Scientific Influence

Professor Alberto Leyva has made a significant impact on the global scientific community through his publications in internationally recognized journals 🌍📚. His research contributions in pharmaceutical, biotechnological, and regulatory fields have been widely cited, reflecting his influence on industry practices and scientific advancements 🧪💊. Being fluent in Spanish and English 🗣️, he actively engages with researchers worldwide, fostering international collaborations 🤝. His expertise extends beyond academia, shaping biopharmaceutical innovations and regulatory standards . Through his dedication and global reach, he continues to drive progress in microbiology and biotechnology, leaving a lasting mark on the scientific world.

Industry Impact

Professor Alberto Leyva has made a profound impact on the biopharmaceutical industry through his expertise in monoclonal antibodies, recombinant protein quantification, and process control 🧪💊. His research plays a crucial role in healthcare advancements by ensuring precision in pharmaceutical production. Additionally, his work on water purification, air quality validation, and critical system design contributes to maintaining high industry standards 💧. The practical applications of his research extend beyond academia, directly influencing industrial biotechnology and pharmaceutical innovations. His dedication to quality and efficiency continues to shape global biopharmaceutical manufacturing and regulatory practices.

Research Focus

Professor Alberto Leyva specializes in biopharmaceutical analysis 🧪, with a research focus on stability-indicative assays and conformation-specific immunoassays 🧬 for biologics, particularly recombinant human gamma interferon (rhIFN-γ) 💉. His work involves developing enzyme-linked immunosorbent assays (ELISA) 🏥 to assess the stability, integrity, and conformational changes of therapeutic proteins. This research is crucial for biopharmaceutical quality control 🔬, ensuring the efficacy and safety of protein-based drugs. His expertise spans protein characterization, immunoassay development, and biologics stability testing, contributing to regulatory compliance 📜 and the advancement of precision medicine .

Publication Top Notes

Stability-indicative and conformation-specific enzyme linked immunosorbent assay for analysis of recombinant human gamma interferon

Yuzhu Cai | Pharmacology | Best Researcher Award

Published on 08/03/202508/03/2025 by Top Pharmaceutical

Yuzhu Cai | Pharmacology | Best Researcher Award

Dr. Yuzhu Cai, Beihang University, China

Dr. Yuzhu Cai is a dedicated researcher in software engineering, currently pursuing a Ph.D. at Beihang University, China. He earned his Bachelor’s degree in Information Security with a Mathematics minor from Nankai University. An award-winning innovator, he has secured top honors in national competitions, including cryptography, algorithm design, and mathematical modeling. His research spans AI ethics, cybersecurity, and password security, with notable publications in Cell Patterns and ICLR 2025. Co-founder of Han Hai Xing Tu Technology, he pioneers AI-driven educational platforms. His contributions in cryptography and AI showcase his passion for innovation and security. ✨📊

Publication Profile

Google scholar

Education

Dr. Yuzhu Cai 🎓 is a dedicated scholar in the field of software engineering. He is currently pursuing his Ph.D. in Software Engineering at Beihang University, Tianjin, China (Sept 2024 – Present) 🖥️. Prior to this, he earned his Bachelor of Science in Information Security from Nankai University (Sept 2020 – Jul 2024) 🔐. Alongside his major, he also pursued a Minor in Mathematics (Sept 2021 – June 2023) ➗, further strengthening his analytical skills. With a strong academic foundation and a passion for innovation, Dr. Cai continues to advance in the field of technology and cybersecurity.

Awards

Dr. Yuzhu Cai 🎖️ has received numerous prestigious awards for his excellence in information security, cryptography, and mathematics. He secured First Prize in the National Information Works Competition 🏆, along with the Most Innovative and Entrepreneurial Value Award. He also won First Prize in the 7th National Cryptography Technology Competition 🔐 and the National College Students’ Mathematical Modeling Competition (Tianjin Area) 📊. His achievements include a Bronze Medal in the National Algorithm Design and Programming Challenge 💻 and First Prize in the Tianjin Electronic Design Competition. Additionally, he earned multiple scholarships 🏅, including Nankai University’s Public Ability and Innovation Scholarships. 🚀

Scientific Contributions

Dr. Yuzhu Cai 🧑‍🔬 has made remarkable contributions to the field of artificial intelligence and cybersecurity. He has co-authored influential publications in top-tier journals like Cell Patterns 📄 and presented groundbreaking research at ICLR 2025 🤖, focusing on AI ethics and multi-agent collaboration networks. His ongoing studies delve into password security 🔐, large language models (LLMs) 🧠, and AI-driven educational platforms 🎓, showcasing his dedication to cutting-edge innovation. With a strong research portfolio and a passion for technological advancements, Dr. Cai continues to shape the future of AI and cybersecurity. 🚀

Industry

Beyond academic research, Dr. Yuzhu Cai 🌟 has played a key role in applied technology projects, bridging the gap between innovation and real-world solutions. He contributed to HoneyCloud ☁️🔐, a secure multi-cloud password manager, enhancing cybersecurity practices. Additionally, he was involved in Han Hai Xing Tu 🎓🤖, an AI-driven educational planning platform, revolutionizing personalized learning. His entrepreneurial mindset 💡 and collaborative research efforts strengthen his influence across both academia and industry. With a passion for technological advancement and practical solutions, Dr. Cai continues to drive impactful innovations in AI, security, and education.

Research Focus

Dr. Yuzhu Cai’s research focuses on ensuring the ethical use of AI, particularly in aligning open-source text-to-image models with societal values. In the paper “Ethical-Lens: Curbing Malicious Usages of Open-Source Text-to-Image Models,” Dr. Cai and colleagues introduce Ethical-Lens, a framework designed to prevent the generation of harmful or biased content by these models. This framework operates without altering the internal structures of existing models, instead refining user inputs and adjusting outputs to adhere to ethical standards. By addressing issues like toxicity and bias, Ethical-Lens aims to promote the responsible development and integration of AI tools into society.

Publication Top Notes

Self-evolving multi-agent collaboration networks for software development

Ethical-lens: Curbing malicious usages of open-source text-to-image models

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Published on 08/03/202508/03/2025 by Top Pharmaceutical

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Assist. Prof. Dr. Nibras Mohammed Sahi, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nebras Mohammed Sahi 🦋, an Assistant Professor at the University of Babylon, specializes in entomology and plant extracts 🌿. Her research explores insect-derived products and medicinal plant applications in anticancer and antibacterial treatments 🧪. She has contributed to high-impact journals 📄 indexed in SCI and Scopus. Dr. Sahi prepared the propolis and Alhagi maurorum extract used in her latest research. Her work advances medicine, agriculture, and sustainability 🌍. With a citation index of 3, she actively collaborates on innovative biological studies. 💡🔬

Publication Profile

orcid

Professional Background

Dr. Nibras Mohammed Sahi 🦋, an Assistant Professor, specializes in entomology and plant extracts, focusing on the study of insects and their beneficial products. Her research explores the diverse applications of insect-derived compounds in medicine 💊, agriculture 🌱, and sustainability 🌍. Through collaborations with universities and research institutions, she investigates innovative ways to harness the potential of insects for ecological and economic benefits. Driven by a passion for scientific discovery 🔬, Dr. Sahi’s work contributes to advancements in bio-based solutions, aiming to enhance environmental conservation and agricultural productivity while promoting sustainable development.

Ongoing Research

Dr. Nibras Mohammed Sahi 🦋 is actively engaged in research on insect-derived products and plant extracts, with a particular focus on propolis 🐝 and Alhagi maurorum 🌿 for cancer 🧬 and antibacterial 🦠 applications. Her studies explore the therapeutic potential of these natural compounds, aiming to develop innovative solutions in medicine 💊 and biotechnology. While her work aligns with prestigious award categories, highlighting specific project funding 💰, collaborations 🤝, or research grants would further strengthen her academic profile. Through her dedication to scientific discovery 🔬, Dr. Sahi contributes to advancements in natural product research and sustainable healthcare solutions.

Professional Memberships

Dr. Nibras Mohammed Sahi 🦋 has not listed any editorial appointments, active collaborations, or professional memberships. However, participation in scientific societies 🏛️, international conferences 🎤, or editorial boards 📑 would significantly enhance her academic profile. Engaging in peer-reviewed journals 📚, contributing to scientific committees 🏅, or collaborating on global research initiatives 🌍 would further establish her influence in the field of entomology and natural product research. Highlighting such professional engagements would strengthen her candidacy, showcasing her dedication to advancing scientific knowledge 🔬 and fostering collaborations that drive innovation in medicine 💊, agriculture 🌱, and sustainability 🌿.

Research Focus

Assist. Prof. Dr. Nibras Mohammed Sahi’s research primarily focuses on microbiology 🦠, antibiotic resistance 💊, and bioactive compounds 🌱. His studies encompass pathogenic bacteria identification 🧫, antimicrobial activity testing 🧪, and molecular genetics 🧬 related to infectious diseases. He has extensively investigated natural plant extracts 🌿 and fungal metabolites 🍄 for their antibacterial and antifungal properties, along with genetic factors in diseases 🧑‍⚕️ like hepatitis B and colorectal cancer. His work also extends to insecticidal bioactive compounds 🪲 and their effects. His research contributes significantly to public health 🏥, pharmacology 💉, and molecular diagnostics 🔬.

Publication Top Notes

Molecular & Antibiotic Sensitivity Pattern Study of Acute Otitis Media, Tonsillitis & Periodontitis among Different Ages of Patients of Al-Hashmia General Hospital, Primary Care Centers & Private Clinic in Babylon Province

Analysis of Methanolic extract of Secondary Metabolites Released by Candida glabratus using GC-MS and Evaluation of Its Antimicrobial Activity

Detection of Bioactive Compounds of Raphanus sativus Using GC-MS and FT-IR Technical Analysis and Determination of its Anti-Bacterial and Anti-Fungal Activity.

Isolation and Identification of Some Pathogenic Bacteria from Otitis Media in Babylon Governorate

Antimicrobial Effect of the Crude Phenolic, Alkaloid and Terpenoid Compounds Extracts of Myrtus Communis L. against Human Gram-Negative Pathogenic Bacteria

Mifleh Tatour | Gastrointestinal Pharmacology | Best Researcher Award

Published on 07/03/202507/03/2025 by Top Pharmaceutical

Mifleh Tatour | Gastrointestinal Pharmacology | Best Researcher Award

Dr. Mifleh Tatour, Clalit Health Services, Israel

Dr. Mifleh Tatour (b. 1989, Israel) is a distinguished physician and researcher specializing in family medicine and hematology. He earned his M.D. from the Technion – Israel Institute of Technology and holds an M.Sc. in Hematology and Cancer. A prolific researcher, he has published extensively on autoimmune hepatitis and heparanase activity. Currently, he serves as a family medicine resident at Clalit Health Services and a lecturer at Bar-Ilan University. Passionate about medical education, he mentors aspiring physicians. Fluent in Hebrew and Arabic, Dr. Tatour is committed to advancing healthcare and medical training. 🏥🔬

Publication Profile

orcid

Education

Dr. Mifleh Tatour 🎓 is a distinguished medical professional with a strong background in hematology, cancer research, and hepatology. He earned his B.Sc. (Cum Laude) in Medical Laboratory Sciences (2008-2012) and an M.Sc. (Cum Laude) in Hematology and Cancer (2013-2015) from the Technion – Israel Institute of Technology 🏥. He later completed his M.D. (2014-2019) at the same institution. Dr. Tatour has contributed to multiple high-impact publications, including studies on autoimmune hepatitis and heparanase activity. In 2024, he was accepted into the prestigious “Northern Stars” program 🌟 at Bar-Ilan University. His research continues to shape the future of hepatology and oncology.

Work Experience

Dr. Mifleh Tatour 🩺 is an accomplished medical educator and family medicine specialist. Since 2021, he has been a Family Medicine Resident at Clalit Health Services – Northern District, while also serving as a lecturer and instructor at Bar-Ilan University’s Faculty of Medicine 🎓. He directs the “Bread and Butter” course for first-year residents and mentors students in various programs. Previously, he worked at Emek Medical Center and Carmel Medical Center. Passionate about education, he has trained students in hematology, psychometrics, and medical school preparation 📚. His dedication to teaching and mentoring continues to shape future healthcare professionals.

Clinical Impact

Dr. Mifleh Tatour 🏥 is a dedicated Family Medicine Resident at Clalit Health Services, seamlessly integrating clinical practice, research, and education. With experience as a physician assistant, internal medicine instructor, and hematology lab instructor, he has developed a comprehensive medical expertise 🩺. His commitment to patient care is complemented by his passion for teaching, mentoring future doctors, and advancing medical knowledge 📚. Through his roles in academia and clinical settings, Dr. Tatour continues to make a significant impact on healthcare, ensuring high-quality treatment while shaping the next generation of physicians 👨‍⚕️.

Research Focus

Dr. Mifleh Tatour’s research primarily focuses on the intersection of autoimmune diseases 🦠 and hematological malignancies 🧬, particularly the increased risk of Non-Hodgkin Lymphoma (NHL) in patients with Autoimmune Hepatitis (AIH) 🏥. His work involves large-scale retrospective cohort studies 📊 to identify potential pathophysiological links 🔬 between chronic liver inflammation and lymphoproliferative disorders. His research aims to improve early detection 🛑 and risk assessment ⚠️ for AIH patients susceptible to lymphoma, contributing to personalized medicine 🏥 and better clinical outcomes 📈. His work is significant in the fields of gastroenterology, immunology, and oncology 🩺.

Publication Top Notes

Increased Risk of Non-Hodgkin Lymphoma in Autoimmune Hepatitis: A Large Retrospective Cohort Study

Tiziana Russo Spena | Pharmaceutical Biotechnology | Best Paper Award

Published on 07/03/202507/03/2025 by Top Pharmaceutical

Tiziana Russo Spena | Pharmaceutical Biotechnology | Best Paper Award

Prof. Tiziana Russo Spena, Dipartimento di Economia management Istituzioni, Università degli Studi di Napoli Federico II, Italy

Prof. Tiziana Russo Spena is a Full Professor of Economics and Business Management at the University of Naples Federico II 🇮🇹. She holds a Ph.D. in Business Economics and specializes in digital health, sustainable business models, and stakeholder engagement 🔬💡. She has led multiple national and international research projects, including initiatives on blockchain in the agri-food sector, interactive robotics for aging well, and digital health services 🤖🌿. With extensive academic contributions, she plays a key role in shaping innovative business strategies and economic frameworks. 📚🏆

Publication Profile

Scopus

Education

Prof. Tiziana Russo Spena 🎓 is a distinguished Full Professor of Economics and Business Management (2022). She earned her Ph.D. in Business Economics (2002-2005) from the Faculty of Economics, University of Naples Federico II. Prior to that, she completed a Master’s in Investment Project Evaluation (2002) at the Research Centre of Urban and Territorial Management (L.U.P.T). Her academic journey began with a Degree in Business and Administration (1998), graduating with top honors (110/110 cum laude) from the same university. With a strong foundation in business and economics, she has made remarkable contributions to the field. 📚💼

Institutional And Membership

Prof. Tiziana Russo Spena 🎓 is an active member of the academic and research community, contributing to various institutional and membership activities. In 2024, she joined the Editorial Board of the International Journal of Research in Marketing and became the Coordinator of the Ph.D. Program in Management at the University of Naples Federico II. She serves as a board member of ReSER and CAISIAL, a treasurer at ReSER, and a key member of the Ateneo Commission for Internationalization. Additionally, she co-founded the Italian Blockchain National Observatory and leads advanced training courses in social media marketing and blockchain. 🔗📚

Awards

Prof. Tiziana Russo Spena 🏆 has received numerous prestigious awards for her research and contributions. In 2022, her article on COVID-19’s impact won the Highly Commended Paper award. She earned the Outstanding Paper Award (2013) for her work on store experience and co-creation. Her research on food innovation won the Best Paper Award (2013) at Lucerne University. Recognized as a Pioneer of Human Side of Service Engineering (2012), she was also a finalist in the Start Cup-Campania Competition (2011). Additionally, she received the Best Service Innovation Thinking Award (2008) and the Roberto Marrama Prize (2004). 🏅

Teaching Activities

Prof. Tiziana Russo Spena 🎓 has an extensive teaching career spanning various disciplines in business and management. Since 2019, she has been a Professor of Ethics and Management at the University of Naples Federico II. She also teaches Management (2018–present) and Marketing of Pharmaceutical Products (2012–present). Previously, she taught International Management (2013–2019), Retail Management (2013–2016), and International Marketing (2016–2018). She was a Visiting Professor in Brazil (2013) and an Assistant Professor at Magna Graecia University (1994–2012). Her contributions span agrifood, non-profits, and international trade, shaping future business leaders. 📚

Research Focus

Professor Tiziana Russo Spena specializes in service innovation, digital transformation, and customer experience, particularly in emerging digital ecosystems. Her research focuses on topics such as the phygital customer journey 🛍️📱, human-robot collaboration 🤖🤝, the metaverse in business and marketing 🌐🎭, and technology-enabled value co-creation 💡🔗. She explores how smart technologies and AI-driven solutions enhance consumer engagement and service management. Additionally, she investigates the role of innovation ecosystems in cultural heritage 🏛️📜. Her interdisciplinary approach integrates marketing, digital services, and technology management, shaping the future of service design and digital customer interactions.

Publication Top Notes

Unravelling the customer journey: A conceptual framework and research agenda

Phygital customer journey: a practice-based approach

A system and learning perspective on human–robot collaboration

Experimenting on the metaverse to foster innovation

HCAI-Based Service Provision for an Engaged University

Agencement of onlife and phygital: smart tech–enabled value co-creation practices

Innovative value propositions in the fashion metaverse

Addressing Socio-Material Issues for an Emerging Innovation Ecosystem: Insights From Cultural Heritage